Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    EU Returns Supported by Frontex Surpass 33,000 in the First Half of 2026

    September 8, 2026

    Record-Breaking Summer in Italy 2026 Marks Hottest Since 1950

    September 8, 2026

    FAO Predicts 2026 Cereal Harvest to Fall Short of Record Levels

    September 7, 2026
    Gourock TimesGourock Times
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    Gourock TimesGourock Times
    Home » Breakthrough pacemaker injected via syringe dissolves in body
    Health

    Breakthrough pacemaker injected via syringe dissolves in body

    April 4, 2025
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    Scientists at Northwestern University have developed the world’s smallest injectable pacemaker, marking a significant advancement in temporary cardiac care, especially for newborns with congenital heart defects. The device, smaller than a grain of rice, is designed to be inserted via a syringe and dissolve harmlessly in the body after use, eliminating the need for surgical removal. Engineered for temporary use, the pacemaker is tailored to provide critical cardiac pacing support during the immediate postoperative recovery phase in infants undergoing heart surgery.

    Breakthrough pacemaker injected via syringe dissolves in body

    According to John A. Rogers, a leading figure in bioelectronics at Northwestern, the device addresses a long-standing need in pediatric cardiology, where the size of existing devices has limited their utility in neonatal patients. The device operates in tandem with a wireless, flexible wearable system that adheres to the patient’s chest. This external unit monitors cardiac activity and, upon detecting irregular rhythms, emits light pulses that non-invasively activate the pacemaker. The light penetrates the skin, breastbone, and surrounding tissue to stimulate the implanted unit.

    All components of the pacemaker are biocompatible and dissolve naturally into the body’s biofluids once they are no longer needed. This eliminates the requirement for a second surgical procedure to extract the device, reducing the overall physical burden on the patient, particularly important in fragile newborns. Igor Efimov, an experimental cardiologist at Northwestern who co-led the project, emphasized the device’s relevance to pediatric care.

    World’s smallest pacemaker dissolves after use

    He noted that approximately 1% of children are born with congenital heart defects and often require temporary pacing for only a few days post-surgery. The new pacemaker offers a non-invasive solution that aligns with this short-term need. The researchers highlighted that multiple units can be deployed simultaneously on the heart to achieve synchronized pacing. Furthermore, the system may be integrated with other implantable devices, such as heart valve replacements, to provide pacing support when complications like heart block arise.

    Because of its size and dissolvable nature, the pacemaker is also suitable for broader medical applications. Rogers indicated the technology could be used to enhance existing implants and support recovery from a range of conditions by providing targeted stimulation. The innovation expands the potential for bioelectronic medicines beyond cardiac care, with possible applications in nerve regeneration, bone healing, wound treatment, and pain management. – By MENA Newswire News Desk.

    Related Posts

    Over Half of EU Adults Are Overweight or Obese, with Obesity Reaching 16.3% in 2025

    September 7, 2026

    Global Efforts Accelerate as DRC Ebola Crisis Continues to Escalate

    September 2, 2026

    Bioactive Coating Enhances Cell Compatibility on Titanium Implants, Study Finds

    August 19, 2026

    European Union’s €2.3 Million Aid Bolsters Efforts to Combat Cholera in Africa

    August 18, 2026

    Guanabenz, an antihypertensive drug, shows potential to slow decline in childhood VWM, study finds

    August 17, 2026

    Congo’s Ebola Crisis Threatens to Outpace the Deadliest Outbreak in History

    August 15, 2026
    Editor's Pick

    EU Returns Supported by Frontex Surpass 33,000 in the First Half of 2026

    September 8, 2026

    Record-Breaking Summer in Italy 2026 Marks Hottest Since 1950

    September 8, 2026

    FAO Predicts 2026 Cereal Harvest to Fall Short of Record Levels

    September 7, 2026

    Over Half of EU Adults Are Overweight or Obese, with Obesity Reaching 16.3% in 2025

    September 7, 2026

    Russia’s Non-Resource Industrial Exports Surpass $58.8 Billion in First Half of 2026

    September 5, 2026

    Brazil Prepares to Retaliate Against EU Meat Ban Amid Diplomatic Dispute

    September 5, 2026

    Nvidia signs $12.93 billion Hugging Face purchase deal

    September 4, 2026

    Overnight stays in the EU reach 1.321 billion in first half of 2026, marking a slight increase

    September 3, 2026
    © 2024 Gourock Times | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.